New dengue drug trial aims to knock out virus faster
NCT ID NCT06551844
First seen May 10, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests experimental antiviral drugs in people with early dengue fever (less than 48 hours of symptoms). About 500 participants will receive either an experimental drug or standard care to see if the drug can clear the virus faster and reduce complications. The goal is to find safe treatments that shorten illness and prevent severe disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital for Tropical Diseases, Ho Chi Minh city
RECRUITINGHo Chi Minh City, 700000, Vietnam
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Universiti Malaya Medical Centre
NOT_YET_RECRUITINGKuala Lumpur, 59100, Malaysia
Contact
Conditions
Explore the condition pages connected to this study.